Parental knowledge of antibiotic use in children with respiratory infections: a systematic review

Lourdes Cantarero-Arévalo1, Mia Pavelics Hallas1, Susanne Kaae1

  • 1Section for Social and Clinical Pharmacy, Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Abstract

Insights

Parental knowledge significantly influences antibiotic use for pediatric upper respiratory tract infections (URTIs). Providing clear explanations and contingency plans improves parental satisfaction, even without antibiotic prescriptions.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • Antimicrobial resistance (AMR) is a growing global health crisis, largely driven by the misuse and overuse of antibiotics.
  • Upper respiratory tract infections (URTIs) in children are frequently treated with antibiotics, contributing to the development of AMR.

Purpose of the Study:

  • To examine parental knowledge, attitudes, and behaviors regarding antibiotic use for pediatric URTIs.
  • To understand factors influencing parental decisions about antibiotic prescriptions for children's common colds.

Main Methods:

  • A systematic review of qualitative and quantitative studies was conducted.
  • Searched EMBASE and PubMed databases for relevant articles published in English, French, Spanish, and Scandinavian languages up to May 2016.
  • Extracted data on study characteristics, parental knowledge, attitudes, behaviors, and demographics.

Main Results:

  • Parental knowledge about URTIs and appropriate antibiotic use is a key factor in prescribing behavior.
  • Higher socioeconomic status and living in Western countries correlate with better knowledge but not always judicious antibiotic use.
  • Effective communication, including providing contingency plans and explaining why antibiotics are unnecessary for viral infections, enhances parental satisfaction with healthcare providers.

Conclusions:

  • Parental knowledge remains crucial in guiding appropriate antibiotic use for pediatric URTIs.
  • Physicians can improve patient outcomes and combat AMR by educating parents and offering alternative management strategies, such as contingency plans, rather than solely relying on antibiotic prescriptions.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
586
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
628
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
304
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
405
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K